Kazia Therapeutics Limite... (KZIA)
NASDAQ: KZIA
· Real-Time Price · USD
7.30
-0.03 (-0.41%)
At close: Sep 26, 2025, 3:59 PM
7.36
0.82%
After-hours: Sep 26, 2025, 05:15 PM EDT
-0.41% (1D)
| Bid | 7.33 |
| Market Cap | 4.2M |
| Revenue (ttm) | 2.48M |
| Net Income (ttm) | -26.78M |
| EPS (ttm) | -29.49 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | -788 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 8 |
| Volume | 4,549 |
| Avg. Volume (20D) | 273,814 |
| Open | 7.40 |
| Previous Close | 7.33 |
| Day's Range | 7.30 - 7.58 |
| 52-Week Range | 2.86 - 39.05 |
| Beta | 2.20 |
| Ex-Dividend Date | n/a |
About KZIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KZIA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KZIA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+39.53%
Kazia Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+81.37%
Kazia Therapeutics shares are trading higher after the company announced it published preclinical data on paxalisib in the journal Molecular Cancer Therapeutics.
